129 related articles for article (PubMed ID: 12716760)
1. A novel role for CD36 in VLDL-enhanced platelet activation.
Englyst NA; Taube JM; Aitman TJ; Baglin TP; Byrne CD
Diabetes; 2003 May; 52(5):1248-55. PubMed ID: 12716760
[TBL] [Abstract][Full Text] [Related]
2. The in vitro effects of chylomicron remnant and very low density lipoprotein remnant on platelet aggregation in blood obtained from healthy persons.
Mochizuki M; Takada Y; Urano T; Nagai N; Nakano T; Nakajima K; Takada A
Thromb Res; 1996 Mar; 81(5):583-93. PubMed ID: 8907317
[TBL] [Abstract][Full Text] [Related]
3. Activation of human platelets by misfolded proteins.
Herczenik E; Bouma B; Korporaal SJ; Strangi R; Zeng Q; Gros P; Van Eck M; Van Berkel TJ; Gebbink MF; Akkerman JW
Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1657-65. PubMed ID: 17510465
[TBL] [Abstract][Full Text] [Related]
4. Large triglyceride-rich lipoproteins from fasting patients with type 2 diabetes activate platelets.
Boulet MM; Cheillan D; Di Filippo M; Buisson C; Michalski MC; Moulin P; Calzada C
Diabetes Metab; 2020 Feb; 46(1):54-60. PubMed ID: 30981822
[TBL] [Abstract][Full Text] [Related]
5. PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Enhances Platelet Activation, Thrombosis, and Myocardial Infarct Expansion by Binding to Platelet CD36.
Qi Z; Hu L; Zhang J; Yang W; Liu X; Jia D; Yao Z; Chang L; Pan G; Zhong H; Luo X; Yao K; Sun A; Qian J; Ding Z; Ge J
Circulation; 2021 Jan; 143(1):45-61. PubMed ID: 32988222
[TBL] [Abstract][Full Text] [Related]
6. Distinct roles of GPVI and integrin alpha(2)beta(1) in platelet shape change and aggregation induced by different collagens.
Jarvis GE; Atkinson BT; Snell DC; Watson SP
Br J Pharmacol; 2002 Sep; 137(1):107-17. PubMed ID: 12183336
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a role for phospholipase C, but not phospholipase A2, in platelet activation in response to low concentrations of collagen.
Lockhart LK; Pampolina C; Nickolaychuk BR; McNicol A
Thromb Haemost; 2001 May; 85(5):882-9. PubMed ID: 11372683
[TBL] [Abstract][Full Text] [Related]
8. Effects of VLDL, chylomicrons, and chylomicron remnants on platelet aggregability.
Orth M; Luley C; Wieland H
Thromb Res; 1995 Aug; 79(3):297-305. PubMed ID: 8533125
[TBL] [Abstract][Full Text] [Related]
9. Signaling role of CD36 in platelet activation and thrombus formation on immobilized thrombospondin or oxidized low-density lipoprotein.
Nergiz-Unal R; Lamers MM; Van Kruchten R; Luiken JJ; Cosemans JM; Glatz JF; Kuijpers MJ; Heemskerk JW
J Thromb Haemost; 2011 Sep; 9(9):1835-46. PubMed ID: 21696539
[TBL] [Abstract][Full Text] [Related]
10. Remnant-like lipoproteins stimulate whole blood platelet aggregation in vitro.
Knöfler R; Nakano T; Nakajima K; Takada Y; Takada A
Thromb Res; 1995 Apr; 78(2):161-71. PubMed ID: 7482433
[TBL] [Abstract][Full Text] [Related]
11. Exosome poly-ubiquitin inhibits platelet activation, downregulates CD36 and inhibits pro-atherothombotic cellular functions.
Srikanthan S; Li W; Silverstein RL; McIntyre TM
J Thromb Haemost; 2014 Nov; 12(11):1906-17. PubMed ID: 25163645
[TBL] [Abstract][Full Text] [Related]
12. Effect of vitamin E supplementation on platelet thromboxane A2 production in type I diabetic patients. Double-blind crossover trial.
Gisinger C; Jeremy J; Speiser P; Mikhailidis D; Dandona P; Schernthaner G
Diabetes; 1988 Sep; 37(9):1260-4. PubMed ID: 3044891
[TBL] [Abstract][Full Text] [Related]
13. Postprandial Triglyceride-Rich Lipoproteins from Type 2 Diabetic Women Stimulate Platelet Activation Regardless of the Fat Source in the Meal.
Boulet MM; Cheillan D; Di Filippo M; Lelekov-Boissard T; Buisson C; Lambert-Porcheron S; Nazare JA; Tressou J; Michalski MC; Calzada C; Moulin P
Mol Nutr Food Res; 2020 Oct; 64(19):e2000694. PubMed ID: 32844550
[TBL] [Abstract][Full Text] [Related]
14. Differential roles of integrins alpha2beta1 and alphaIIbbeta3 in collagen and CRP-induced platelet activation.
Jarvis GE; Best D; Watson SP
Platelets; 2004 Aug; 15(5):303-13. PubMed ID: 15370101
[TBL] [Abstract][Full Text] [Related]
15. Hydrogen peroxide as trigger of platelet aggregation.
Praticò D; Iuliano L; Ghiselli A; Alessandri C; Violi F
Haemostasis; 1991; 21(3):169-74. PubMed ID: 1773986
[TBL] [Abstract][Full Text] [Related]
16. Aggregation of human blood platelets by remnant like lipoprotein particles of plasma chylomicrons and very low density lipoproteins.
Saniabadi AR; Umemura K; Shimoyama M; Adachi M; Nakano M; Nakashima M
Thromb Haemost; 1997 May; 77(5):996-1001. PubMed ID: 9184417
[TBL] [Abstract][Full Text] [Related]
17. Alteration of release and role of adenosine diphosphate and thromboxane A2 during collagen-induced aggregation of platelets from cattle with Chediak-Higashi syndrome.
Honda N; Ohnishi K; Fujishiro T; Ikeda M; Ito K
Am J Vet Res; 2007 Dec; 68(12):1399-406. PubMed ID: 18052747
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production.
Cattaneo M; Lombardi R; Zighetti ML; Gachet C; Ohlmann P; Cazenave JP; Mannucci PM
Thromb Haemost; 1997 May; 77(5):986-90. PubMed ID: 9184415
[TBL] [Abstract][Full Text] [Related]
19. Normal aggregations of glycoprotein IV (CD36)-deficient platelets from seven healthy Japanese donors.
Yamamoto N; Akamatsu N; Yamazaki H; Tanoue K
Br J Haematol; 1992 May; 81(1):86-92. PubMed ID: 1381610
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory mechanisms of resveratrol in platelet activation: pivotal roles of p38 MAPK and NO/cyclic GMP.
Shen MY; Hsiao G; Liu CL; Fong TH; Lin KH; Chou DS; Sheu JR
Br J Haematol; 2007 Nov; 139(3):475-85. PubMed ID: 17868048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
